Description
A decrease in Factor H levels is observed in the atypical form of hemolytic-uremic syndrome (aHUS), a systemic disease from the group of thrombotic microangiopathies. It is based on uncontrolled activation of the alternative complement pathway of hereditary or acquired nature, leading to generalized thrombus formation in the vessels of the microcirculatory bed.
Period of execution
Within 9 days. The specified time does not include the day of biomaterial collection
Biomaterial type